Heme-containing enzyme

Heme-containing enzymes are a diverse and essential class of proteins that utilize a heme prosthetic group—typically iron-protoporphyrin IX—to facilitate a wide range of biochemical reactions. This group includes the cytochrome P450 (CYP) superfamily, which is responsible for the oxidative metabolism of the majority of clinical drugs and the synthesis of endogenous compounds like steroid hormones and lipids (Source: NCBI, https://www.ncbi.nlm.nih.gov/books/NBK553169/). Other critical members include cyclooxygenases (COX-1 and COX-2), which catalyze the rate-limiting step in prostaglandin synthesis and are central to inflammatory responses (Source: StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK493197/). Additionally, enzymes such as nitric oxide synthase (NOS) and soluble guanylate cyclase (sGC) play pivotal roles in cardiovascular signaling and vasodilation (Source: Nature, https://www.nature.com/articles/nrd2130). Because of their ubiquity and functional importance, heme-containing enzymes are major targets for therapeutic agents, including nonsteroidal anti-inflammatory drugs (NSAIDs), antifungals, and cardiovascular medications. However, the structural conservation of the heme-binding pocket across different enzymes can lead to significant drug-drug interactions and off-target toxicities, making them a complex focus for drug development and safety monitoring (Source: PubMed, https://pubmed.ncbi.nlm.nih.gov/25613566/).

Other names

HemeproteinHeme enzymeIron-protoporphyrin IX-containing enzyme

Inhibition of enzymatic activity via coordination with the heme iron or competitive binding at the active site; stimulation of enzymatic activity through allosteric or direct heme-binding mechanisms.